Watch PMHS. Know when insiders buy.
One email the day a filing lands. Free.
PMHS
Polomar Health Services, Inc.
0.15
+0.01 +7.14%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $4.3MP/E —DIV YIELD —FCF YIELD —REV TTM $3.2M +7688.8%NET INCOME −$9.5MNET CASH —52W 0.06 – 0.80SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.5M | +27847.1% | 61.2% | $218K | $200K | — | 0.00 | $121K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $1M | +22038.2% | 54.7% | −$7K | −$25K | — | 0.00 | $34K | — | — | Jun 1 |
| Q4 2025 · Dec 31 | $632K | +2928.5% | 71.0% | −$8.9M | −$9M | — | -0.33 | $190K | — | — | Jun 1 |
| Q3 2025 · Sep 30 | $6K | −37.4% | 70.1% | −$629K | −$650K | — | -0.02 | −$353K | — | — | Jun 1 |
| Q2 2025 · Jun 30 | $5K | −62.3% | 70.1% | −$563K | −$606K | — | -0.02 | −$188K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | $5K | −66.6% | 70.1% | −$415K | −$457K | — | -0.02 | −$46K | — | — | Jun 1 |
| Q4 2024 · Dec 31 | $21K | +20.7% | 43.5% | −$689K | −$719K | — | -0.03 | −$315K | $0 | −$315K | May 6 |
| Q3 2024 · Sep 30 | $10K | −54.1% | 90.0% | −$259K | −$271K | — | -0.01 | −$292K | $11K | −$303K | Nov 25 |
| Q2 2024 · Jun 30 | $14K | — | 70.8% | −$191K | −$191K | — | -0.01 | −$248K | $39K | −$287K | Aug 19 |
| Q1 2024 · Mar 31 | $14K | — | 19.9% | −$160K | −$160K | — | -0.01 | −$165K | $41K | −$206K | Aug 19 |
| Q4 2023 · Dec 31 | $17K | — | 87.1% | −$95K | −$128K | — | -0.01 | −$220K | — | — | May 22 |
| Q3 2023 · Sep 30 | $21K | — | 92.9% | −$135K | −$172K | — | -0.01 | −$150K | — | — | Mar 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $648K | 71.0% | −$10.6M | −$10.7M | -1650.8% | -0.39 | −$396K | — | — | — | — |
| FY2024 · to Dec 31 | $59K | 52.5% | −$1.3M | −$1.3M | -2280.2% | -0.05 | −$1M | $91K | −$1.1M | — | — |
| FY2023 · to Dec 31 | $42K | 89.7% | −$441K | −$588K | -1405.2% | -0.02 | −$534K | — | — | — | — |
| FY2022 · to Dec 31 | $35K | 100.0% | −$181K | −$181K | -524.6% | 0.00 | −$41K | — | — | — | — |
Every number comes from Polomar Health Services, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.